Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05672667 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects
A Phase 1 study of Healthy Volunteer Study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05672667 is a Phase 1 study of Healthy Volunteer Study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 25 participants, below the 34-participant average among 9 other Healthy Volunteer Study trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05672667, a Phase 1 study of Healthy Volunteer Study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to sample blood and model the plasma pharmacokinetics (PK) of a single dose of intravenous (IV) oxytocin and a single dose of intranasal (i.n.) oxytocin. This is an unblinded study of subjects, all of whom will receive an intravenous (IV) infusion and intranasal (i.n.) dose of oxytocin (a naturally occurring hormone that is made in the brain) with blood samples taken thereafter in order to create a formula to describe the concentrations of oxytocin in the blood over time (pharmacokinetics). In this study healthy volunteers and people are recruited for a two day study. Each study participant will have 2 IV catheters placed (one in each arm) for the day of IV oxytocin dosing and 1 IV catheter on the day of i.n. oxytocin dosing. After placement of the IV catheters, an infusion of oxytocin will be given over a 30 minute period. Blood samples will be taken after the infusion begins and several times during and after the infusion. The blood will be drawn through the IV catheter not used for the oxytocin infusion. For the intranasal oxytocin administration day, 1 IV catheter will be placed and several blood samples will be taken after administration.
Conditions Studied
Interventions
- DRUG intravenous oxytocin
- DRUG intranasal oxytocin
Study Locations (1)
North Carolina
- Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-02-27 |
| Est. Completion | 2023-11-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05672667
The ClinicalTrials.gov registry entry for NCT05672667 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 34-participant average among 9 other Healthy Volunteer Study trials with a reported enrollment target (26% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteer Study appearing as the primary indexed condition, and to 2 interventions - of which intravenous oxytocin is the first listed.
NCT05672667 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05672667 about?
NCT05672667 is a clinical study titled "A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects". The main purpose of this study is to sample blood and model the plasma pharmacokinetics (PK) of a single dose of intravenous (IV) oxytocin and a single dose of intranasal (i.n.) oxytocin. This is an unblinded study of subjects, all of whom will receive an intravenous (IV) infusion and intranasal (i...
What is the current status of trial NCT05672667?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2023-02-27. Estimated completion is 2023-11-01.
What conditions does trial NCT05672667 study?
This clinical trial studies the following conditions: Healthy Volunteer Study.
What interventions are being tested in trial NCT05672667?
The interventions under investigation include: intravenous oxytocin (DRUG), intranasal oxytocin (DRUG).
Who is sponsoring clinical trial NCT05672667?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05672667 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteer Study
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function
RECRUITING · Phase 1
-
Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation
RECRUITING · Phase 1
-
A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations
COMPLETED · Phase 1
-
Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
COMPLETED · Phase 1
-
Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)
COMPLETED · Phase 1
-
Near-InfraRed Spectroscopy of Auricular Stimulation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.